Geneos Wealth Management’s Vanguard FTSE Emerging Markets ETF VWO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11M | Buy |
203,555
+37,229
| +22% | +$2.09M | 0.26% | 89 |
|
|
2025
Q4 | $8.94M | Buy |
166,326
+11,845
| +8% | +$643K | 0.22% | 115 |
|
|
2025
Q3 | $8.37M | Sell |
154,481
-116,688
| -43% | -$6.01M | 0.21% | 125 |
|
|
2025
Q2 | $13.4M | Sell |
271,169
-102,114
| -27% | -$4.74M | 0.33% | 72 |
|
|
2025
Q1 | $24.4M | Buy |
373,283
+239,018
| +178% | +$10.8M | 0.35% | 67 |
|
|
2024
Q4 | $5.91M | Sell |
134,265
-6,603
| -5% | -$307K | 0.21% | 110 |
|
|
2024
Q3 | $6.74M | Buy |
140,868
+7,800
| +6% | +$347K | 0.26% | 90 |
|
|
2024
Q2 | $5.82M | Buy |
133,068
+6,789
| +5% | +$292K | 0.26% | 86 |
|
|
2024
Q1 | $5.27M | Sell |
126,279
-3,305
| -3% | -$135K | 0.24% | 101 |
|
|
2023
Q4 | $5.33M | Sell |
129,584
-2,001
| -2% | -$79.4K | 0.26% | 94 |
|
|
2023
Q3 | $5.16M | Buy |
131,585
+25,746
| +24% | +$1.05M | 0.27% | 99 |
|
|
2023
Q2 | $4.31M | Buy |
105,839
+28,785
| +37% | +$1.16M | 0.23% | 122 |
|
|
2023
Q1 | $3.11M | Buy |
77,054
+40,367
| +110% | +$1.64M | 0.19% | 140 |
|
|
2022
Q4 | $1.43M | Sell |
36,687
-2,835
| -7% | -$108K | 0.09% | 219 |
|
|
2022
Q3 | $1.44M | Sell |
39,522
-3,150
| -7% | -$128K | 0.1% | 205 |
|
|
2022
Q2 | $1.77M | Buy |
42,672
+2,109
| +5% | +$91.1K | 0.09% | 223 |
|
|
2022
Q1 | $1.87M | Sell |
40,563
-4,978
| -11% | -$239K | 0.08% | 233 |
|
|
2021
Q4 | $2.25M | Buy |
45,541
+17
| +0% | +$857 | 0.09% | 238 |
|
|
2021
Q3 | $2.28M | Buy |
45,524
+1,511
| +3% | +$78.1K | 0.09% | 225 |
|
|
2021
Q2 | $2.37M | Sell |
44,013
-198,348
| -82% | -$10.6M | 0.09% | 211 |
|
|
2021
Q1 | $12.8M | Sell |
242,361
-14,815
| -6% | -$789K | 0.36% | 67 |
|
|
2020
Q4 | $2.08M | Buy |
257,176
+225,832
| +720% | +$10.6M | 0.08% | 229 |
|
|
2020
Q3 | $1.32M | Sell |
31,344
-2,865
| -8% | -$125K | 0.07% | 251 |
|
|
2020
Q2 | $1.35M | Sell |
34,209
-22,366
| -40% | -$828K | 0.08% | 241 |
|
|
2020
Q1 | $1.86M | Buy |
56,575
+4,671
| +9% | +$190K | 0.13% | 174 |
|
|
2019
Q4 | $2.31M | Sell |
51,904
-3,396
| -6% | -$144K | 0.12% | 183 |
|
|
2019
Q3 | $2.22M | Sell |
55,300
-36,638
| -40% | -$1.51M | 0.13% | 171 |
|
|
2019
Q2 | $3.91M | Sell |
91,938
-253
| -0.3% | -$10.6K | 0.24% | 108 |
|
|
2019
Q1 | $3.92M | Sell |
92,191
-12,713
| -12% | -$523K | 0.26% | 106 |
|
|
2018
Q4 | $4.03M | Buy |
104,904
+1,377
| +1% | +$53.3K | 0.3% | 88 |
|
|
2018
Q3 | $4.24M | Sell |
103,527
-91,658
| -47% | -$3.86M | 0.28% | 97 |
|
|
2018
Q2 | $8.24M | Buy |
195,185
+2,128
| +1% | +$96.1K | 0.64% | 28 |
|
|
2018
Q1 | $9.12M | Buy |
193,057
+73,134
| +61% | +$3.51M | 0.8% | 17 |
|
|
2017
Q4 | $5.5M | Buy |
119,923
+6,720
| +6% | +$300K | 0.49% | 51 |
|
|
2017
Q3 | $4.94M | Buy |
113,203
+1,850
| +2% | +$80.1K | 0.49% | 50 |
|
|
2017
Q2 | $4.55M | Buy |
111,353
+2,207
| +2% | +$89.5K | 0.47% | 55 |
|
|
2017
Q1 | $4.37M | Sell |
109,146
-11,288
| -9% | -$436K | 0.45% | 55 |
|
|
2016
Q4 | $4.31M | Sell |
120,434
-7,021
| -6% | -$257K | 0.57% | 41 |
|
|
2016
Q3 | $4.8M | Buy |
127,455
+122,108
| +2,284% | +$4.55M | 0.65% | 35 |
|
|
2016
Q2 | $189K | Buy |
5,347
+1,373
| +35% | +$46.9K | 0.03% | 458 |
|
|
2016
Q1 | $137K | Buy |
+3,974
| New | +$125K | 0.02% | 511 |
|
Other funds holding VWO
VGA
WL
Geneos Wealth Management's VWO Position: Q1 2026 in Review
Geneos Wealth Management increased its Vanguard FTSE Emerging Markets ETF (VWO) stake by 22% in Q1 2026, buying an estimated $2.09M and bringing the position to 203,555 shares worth $11M. The position accounts for 0.26% of the portfolio, ranked #89.
Geneos Wealth Management first reported a position in VWO in Q1 2016 and has held it in 41 quarters since. The position peaked at $24.4M in Q1 2025. 2,536 funds tracked by Wall St. Rank hold VWO as of Q1 2026.
- Geneos Wealth Management held 203,555 shares of Vanguard FTSE Emerging Markets ETF worth $11M as of Q1 2026.
- Geneos Wealth Management bought 37,229 Vanguard FTSE Emerging Markets ETF shares in Q1 2026, an estimated $2.09M.
- Vanguard FTSE Emerging Markets ETF made up 0.26% of Geneos Wealth Management's portfolio in Q1 2026, its #89 holding.
- Geneos Wealth Management first reported a position in Vanguard FTSE Emerging Markets ETF in Q1 2016 and has held it in 41 quarters since.
- Geneos Wealth Management's Vanguard FTSE Emerging Markets ETF position peaked at $24.4M in Q1 2025.
- 2,536 funds tracked by Wall St. Rank held Vanguard FTSE Emerging Markets ETF as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.